Clinical Trial Detail

NCT ID NCT03571321
Title Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Chicago
Indications

acute lymphoblastic leukemia

Therapies

Pegaspargase

Methotrexate

Cytarabine

Mercaptopurine

Thioguanine

Ruxolitinib

Cyclophosphamide

Dexamethasone

Vincristine Sulfate

Rituximab

Doxorubicin

Age Groups: adult

Additional content available in CKB BOOST